Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials. - Patel KR; Nguyen PL; Proudfoot JA; Liu Y; Pra AD; Spratt DE; Pollack A; Sandler HM; Efstathiou JA; Lawton C; Simko JP; Rosenthal SA; et al. (European urology oncology, 2026)